课题基金 / 基金详情

IMPACT OF SEROTONIN REUPTAKE INHIBITORS ON SEX HORMONE LEVELS

IMPACT OF SEROTONIN REUPTAKE INHIBITORS ON SEX HORMONE LEVELS
血清素再摄取抑制剂对性激素水平的影响
批准号:
7604229
负责人:
MARGARET ALTEMUS
金额:
$0.32万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2007-09-16

项目摘要

项目成果

MARGARET ALTEMUS的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 这项研究的主要目的是确定SSRI药物常见的性副作用是否与药物对性腺类固醇激素的影响有关。 该研究调查了血清素再摄取抑制剂(SSRI)抗抑郁药抑制类固醇激素产生的假设。 另一个假设是,在开始SSRI后,由于雄激素水平的降低,性副作用的出现之间存在关联。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The broad objective of the study is to determine whether sexual side effects common with SSRI medications may be associated with the medication's effect on gonadal steroid hormones. The study investigates the hypothesis that serotonin reuptake inhibitors (SSRI) antidepressants suppress production of steroid hormones. And additional hypothesis is that there will be an association between the emergence of sexual side effects after starting an SSRI given the decrease in circulation levels of androgen hormones.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Symptom Onset Antidepressant Treatment for PMDD
Symptom Onset Antidepressant Treatment for PMDD
Symptom Onset Antidepressant Treatment for PMDD
Symptom Onset Antidepressant Treatment for PMDD
海外基金